183
Views
0
CrossRef citations to date
0
Altmetric
Commentary

The liability risks of naloxone access expansion should be the least of our worries

, PhD
Pages 115-116 | Received 24 Dec 2015, Accepted 26 Dec 2015, Published online: 23 Feb 2016

References

  • Office of National Drug Control Policy. National Drug Control Strategy. Washington, DC: Executive Office of the President; 2010.
  • Humphreys K. An overdose antidote goes mainstream. Health Affairs 2015;34:1624–1627.
  • Brodrick JE, Brodrick CK, Adinoff B. Legal regimes surrounding naloxone access: considerations for prescribers. Am J Drug Alc Abuse – this issue.
  • Davis CS, Carr D, Southwell JK, Beletsky L. Engaging law enforcement in overdose reversal initiatives: authorization and liability for naloxone administration. Am J Public Health (in press).
  • Lembke A, Humphreys K, Newmark J. The risks and benefits of chronic opioid therapy. Am Family Physician (in press).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.